Phase II clinical trial of CAStem cell injection in the treatment of acute graft-versus-host disease

General Information
Clinical trials phase	Phase 2
Start date (estimated)	2023-12-01
End date (estimated)	2024-11-30
Clinical feature	Label Graft versus host disease Link http://www.orpha.net/ORDO/Orphanet_39812 Description A rare disease that occurs after allogeneic hematopoietic stem cell transplant and is a reaction of donor immune cells against host tissues. Activated donor T cells damage host epithelial cells after an inflammatory cascade that begins with the preparative regimen.
Administrative Information
ICTRP weblink	https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2300077942
Other study identifiers	Name ChiCTR2300077942 Description Chinese Clinical Trial Registry (ChiCTR)
Source weblink	https://www.chictr.org.cn/showproj.html?proj=201633
Public contact	Email tingniu@sina.com Public email tingniu@sina.com First name Ting Last name Niu Phone +86 189 8060 1242 Country China Address freetext 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan West China Hospital of Sichuan University
Sponsors	West China Hospital of Sichuan University
Cells
Recruitment
Recruitment Status	Recruiting
Estimated number of participants	18